Development of a decision aid for patients with atrial fibrillation who are considering antithrombotic therapy

Malcolm Man-Son-Hing, Andreas Laupacis, Annette M. O'Connor, Robert G. Hart, George Feldman, Joseph L. Blackshear, David C. Anderson

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Abstract

With patients demanding a greater role in the clinical decision-making process, many researchers are developing and disseminating decision aids for various medical conditions. In this article, we outline the essential elements in the development and evaluation of a decision aid to help patients with atrial fibrillation choose, in consultation with their physicians, appropriate antithrombotic therapy (warfarin, aspirin, or no therapy) to prevent stroke. We also outline possible future directions regarding the implementation and evaluation of this decision aid. This information should enable clinicians to better understand the role that decision aids may have in their interactions with patients.

Original languageEnglish (US)
Pages (from-to)723-730
Number of pages8
JournalJournal of general internal medicine
Volume15
Issue number10
DOIs
StatePublished - 2000

Bibliographical note

Funding Information:
This study was supported by grants from the Medical Research Council of Canada, the National Institute of Neurological Disorders and Stroke (RO1 NS 24224), Bethesda, Md, and DuPont Pharma.

Keywords

  • Aspirin
  • Atrial fibrillation
  • Decision aid
  • Warfarin

Fingerprint

Dive into the research topics of 'Development of a decision aid for patients with atrial fibrillation who are considering antithrombotic therapy'. Together they form a unique fingerprint.

Cite this